NCT04888975

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Koya Medical, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the Dayspring Active Wearable Compression Technology in enhancing lymph movement and its safety and effectiveness after lymphatic surgery

Detailed description

To evaluate the Dayspring Active Wearable Compression Technology in enhancing lymph movement and its safety and effectiveness after lymphatic surgery

Conditions

• Lymphedema
• Lymphedema, Breast Cancer
• Lymphedema Arm

Interventions

Type	Name	Description
DEVICE	Dayspring Active Wearable Compression System	Dayspring Active Wearable Compression System

Timeline

• Start date: 2021-06-01
• Primary completion: 2021-12-31
• Completion: 2021-12-31
• First posted: 2021-05-17
• Last updated: 2021-05-20

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study